Norepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 2, 2025

Conditions
HypotensionHypertensionNauseaPainArrhythmia
Interventions
DRUG

Norepinephrine

"The outcome of patient n in each sequence will determine the dose to be allocated patient n+1.~Successive doses will be determined with the up-and-down k-in-row design method for ED90 determination:~* Failure: the dose should be increased in one level (+0.02 µg/kg) after failure to respond (arterial hypotension);~* Success: decrease in one level (-0.02 µg/kg) upon successful response (no arterial hypotension), but only after observing at least k-consecutive positive responses at the same dose (in this case, k=7); otherwise, remain at the same dose.~This will be done until each sequence completes n=30."

Trial Locations (1)

8330024

Hospital Clinico, Pontificia Universidad Catolica de Chile, Santiago

All Listed Sponsors
lead

Pontificia Universidad Catolica de Chile

OTHER